Abstract
Since substance P is a potent natriuretic, diuretic, and vasodilatory peptide, a radioimmunoassay for substance P was developed, and its levels measured in the plasma of normal subjects and patients with essential hypertension. The plasma substance P levels were 186+/-14 pg/ml in normal subjects and 164+/-3 pg/ml in hypertensive patients. When the sodium content of their diet was reduced to 10 mEq/day, substance P levels failed to change, but plasma renin activity and urinary kallikrein increased. An acute saline infusion also failed to alter plasma substance P levels. Assuming an upright posture increased plasma renin activity, but not substance P, in both groups of subjects. Thus, it appears that substance P is not involved in the control of blood pressure, kallikrein excretion or renin release in man.
References
Jun 18, 1979·Life Sciences·H G GullnerW A Pettinger
Jan 15, 1979·Life Sciences·H G GullnerW A Pettinger
Feb 1, 1978·Irish Journal of Medical Science·P SkrabanekD Powell
Oct 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·F LembeckR Gamse
Jun 1, 1976·The American Journal of Physiology·W J ArendshorstI H Mills
Dec 1, 1976·Irish Journal of Medical Science·P SkrabanekD Powell
Dec 1, 1976·Endocrinologia Japonica·C YanaiharaK Yamamoto
Feb 1, 1975·Acta Physiologica Scandinavica·D Hallberg, B Pernow
Aug 1, 1975·Acta Physiologica Scandinavica·G NilssonK Folkers
Jan 1, 1966·International Archives of Allergy and Applied Immunology·P J McConahey, F J Dixon
Feb 1, 1974·The Journal of Clinical Endocrinology and Metabolism·J LanganB J Channick
Jun 1, 1974·Archives of Internal Medicine·N N Kaplan
Oct 15, 1972·Biochemical Pharmacology·M L Mashford, M L Roberts
Jan 11, 1974·Nature·I H MillsP E Ward
Feb 1, 1980·The Journal of Clinical Investigation·O B HollandH Braunstein
Jun 12, 1964·Science·T L GOODFRIENDG D FASMAN
Jun 6, 1931·The Journal of Physiology·U S V Euler, J H Gaddum
Dec 1, 1976·Irish Journal of Medical Science·P SkrabanekD Powell
Citations
Dec 24, 1982·European Journal of Pharmacology·P S VermaR L Miller
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·M D SnavelyP A Insel
Aug 1, 1985·Clinical Physiology·J H HenriksenO B Schaffalitzky De Muckadell
Jun 25, 1986·Brain Research·I H Pang, M R Vasko
Sep 15, 2006·Clinical and Vaccine Immunology : CVI·Donald E CampbellSteven D Douglas